Radiolabeled cannabinoid receptor 2 ligand

US10227308B2 · kind B2 · utility

Assignees

• Hoffmann-La Roche Inc. · US
• Eidgenössische Technische Hochschule Zürich · CH
• UNIVERSITÄT ZÜRICH · CH

Inventors

• Simon M. Ametamey · Bellinzona, CH
• Juergen Fingerle · Kandern, DE
• Luca Gobbi · Muttenz, CH
• Uwe Grether · Weil am Rhein, DE
• Ahmed Haider · Yorba Linda, US
• Thomas Hartung · Soest, DE
• Linjing Mu · Lenzburg, CH
• Leo Nicholls · Leeds, GB
• Mark Rogers-Evans · Bottmingen, CH
• Christoph Ullmer · Fischingen, DE

Key dates

• Filing date: Feb 27, 2017
• Grant date: Mar 12, 2019
• Expiry date: Feb 27, 2037

Classification

• Technology area (CPC G): Physics
• CPC primary: G01N2800/00
• WIPO field: Measurement
• WIPO sector: Instruments

Abstract

The present invention relates to a compound of formula (I) wherein R1 is defined as in the description and in the claims. The compound of formula (I) can be used as radiolabeled ligand.